Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biotechnology Progress|May 12, 2020
Highly sensitive HPLC analysis and biophysical characterization of N-glycans of IgG-Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligandHirofumi Kosuge, Satoru Nagatoishi, Masato Kiyoshi, et al.
Plos One|January 30, 2014
Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complexMasato Kiyoshi, Jose M M Caaveiro, Eri Miura, et al.
Journal of Pharmaceutical Sciences|August 14, 2017
Recent Topics of Research in the Characterization and Quality Control of Biopharmaceuticals in JapanAkiko Ishii-Watabe, Hiroko Shibata, Akira Harazono, et al.
Biologicals : Journal of the International Association of Biological Standardization|December 17, 2018
Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration methodAkira Harazono, Hiroko Shibata, Masato Kiyoshi, et al.
Communications Biology|March 3, 2026
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatographyMasato Kiyoshi, Takuo Suzuki, Naruaki Inoue, et al.
Scientific Reports|October 2, 2023
Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamicsMasato Kiyoshi, Makoto Nakakido, Abdur Rafique, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 24, 2025
Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG ModificationHiroko Kawakami, Abdur Rafique, Shugo Tsuda, et al.
Journal of Pharmaceutical Sciences|February 27, 2026
Flow imaging for particle characterization and quantification in biologicals: A perspective from the Japanese Biopharmaceutical ConsortiumHiroko Shibata, Tim Menzen, Andrea Hawe, et al.
Journal for Immunotherapy of Cancer|March 4, 2026
Antibody therapeutics with high affinity for FcγRs exacerbate anaphylaxis via FcγR-mediated capture by tumor-associated myeloid cellsRuiheng Tang, Aibai Aizemaiti, Yuta Tamemoto, et al.
Scientific Reports|March 4, 2018
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized ColumnMasato Kiyoshi, Jose M M Caaveiro, Minoru Tada, et al.
Pageof 4